Spine BioPharma

Spine

Chris J. StewartSeptember 7, 2022
409

Spine BioPharma Announces First Patient Treated in U.S. Phase 3 Clinical Study

SB-01 For Injection Offers New Potential Treatment for Patients Sufferingfrom Chronic Low Back Pain NEW YORK, September 7, 2022 – OrthoSpineNews…
Read More »
Spine

Josh SandbergMay 11, 2022
867

Spine BioPharma Initiating U.S. Phase 3 Clinical Study

SB-01 For Injection Offers New Potential Treatment for Patients Sufferingfrom Chronic Low Back Pain. New York, NY., May 11, 2022…
Read More »
Financial

Chris J. StewartMarch 28, 2022
218

Spine BioPharma Completes Series B Financing

Proceeds Will Support Clinical Advancement of SB-01 For Injection for Treatment of Degenerative Disc Disease NEW YORK, March 28, 2022 /PRNewswire/ — Spine BioPharma, Inc.,…
Read More »